Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Projecting individualized probabilities of developing bladder cancer in white individuals.

Wu X, Lin J, Grossman HB, Huang M, Gu J, Etzel CJ, Amos CI, Dinney CP, Spitz MR.

J Clin Oncol. 2007 Nov 1;25(31):4974-81.

PMID:
17971596
2.

Predicting risk of breast cancer in postmenopausal women by hormone receptor status.

Chlebowski RT, Anderson GL, Lane DS, Aragaki AK, Rohan T, Yasmeen S, Sarto G, Rosenberg CA, Hubbell FA; Women's Health Initiative Investigators..

J Natl Cancer Inst. 2007 Nov 21;99(22):1695-705. Epub 2007 Nov 13.

PMID:
18000216
3.

Urinary tract diseases and bladder cancer risk: a case-control study.

Jhamb M, Lin J, Ballow R, Kamat AM, Grossman HB, Wu X.

Cancer Causes Control. 2007 Oct;18(8):839-45. Epub 2007 Jun 26.

PMID:
17593531
4.

Bladder cancer, GSTs, NAT1, NAT2, SULT1A1, XRCC1, XRCC3, XPD genetic polymorphisms and coffee consumption: a case-control study.

Covolo L, Placidi D, Gelatti U, Carta A, Scotto Di Carlo A, Lodetti P, Piccichè A, Orizio G, Campagna M, Arici C, Porru S.

Eur J Epidemiol. 2008;23(5):355-62. doi: 10.1007/s10654-008-9238-2.

PMID:
18365755
5.

Prediction of Lynch syndrome in consecutive patients with colorectal cancer.

Green RC, Parfrey PS, Woods MO, Younghusband HB.

J Natl Cancer Inst. 2009 Mar 4;101(5):331-40. doi: 10.1093/jnci/djn499. Epub 2009 Feb 24.

PMID:
19244167
6.

Identifying individuals at high risk of melanoma: a simple tool.

Fortes C, Mastroeni S, Bakos L, Antonelli G, Alessandroni L, Pilla MA, Alotto M, ZappalĂ  A, Manoorannparampill T, Bonamigo R, Pasquini P, Melchi F.

Eur J Cancer Prev. 2010 Sep;19(5):393-400. doi: 10.1097/CEJ.0b013e32833b492f.

PMID:
20520559
7.

Serious renal dysfunction after percutaneous coronary interventions can be predicted.

Brown JR, DeVries JT, Piper WD, Robb JF, Hearne MJ, Ver Lee PM, Kellet MA, Watkins MW, Ryan TJ, Silver MT, Ross CS, MacKenzie TA, O'Connor GT, Malenka DJ; Northern New England Cardiovascular Disease Study Group..

Am Heart J. 2008 Feb;155(2):260-6. doi: 10.1016/j.ahj.2007.10.007. Epub 2007 Nov 26.

PMID:
18215595
8.

Development and validation of a risk score for post-infectious irritable bowel syndrome.

Thabane M, Simunovic M, Akhtar-Danesh N, Marshall JK.

Am J Gastroenterol. 2009 Sep;104(9):2267-74. doi: 10.1038/ajg.2009.302. Epub 2009 Jun 30.

PMID:
19568228
9.

Significance of genetic information in risk assessment and individual classification using silicosis as a case model.

McCanlies E, Landsittel DP, Yucesoy B, Vallyathan V, Luster ML, Sharp DS.

Ann Occup Hyg. 2002 Jun;46(4):375-81.

PMID:
12176706
10.

Probability estimation models for prediction of BRCA1 and BRCA2 mutation carriers: COS compares favourably with other models.

Roudgari H, Miedzybrodzka ZH, Haites NE.

Fam Cancer. 2008;7(3):199-212. Epub 2007 Dec 21.

PMID:
18097771
11.

Gail model risk factors: impact of adding an extended family history for breast cancer.

Crispo A, D'Aiuto G, De Marco M, Rinaldo M, Grimaldi M, Capasso I, Amore A, Bosetti C, La Vecchia C, Montella M.

Breast J. 2008 May-Jun;14(3):221-7. doi: 10.1111/j.1524-4741.2008.00566.x. Epub 2008 Mar 26.

PMID:
18373641
12.

A prediction model for type 2 diabetes risk among Chinese people.

Chien K, Cai T, Hsu H, Su T, Chang W, Chen M, Lee Y, Hu FB.

Diabetologia. 2009 Mar;52(3):443-50. doi: 10.1007/s00125-008-1232-4. Epub 2008 Dec 5.

PMID:
19057891
13.

Bladder cancer risk in patients with spinal cord injury.

Vereczkey ZA, Schmeidler J, Binard JE, Bauman WA.

J Spinal Cord Med. 1998 Jul;21(3):230-9.

PMID:
9863934
14.

The first Latin-American risk stratification system for cardiac surgery: can be used as a graphic pocket-card score.

Carosella VC, Navia JL, Al-Ruzzeh S, Grancelli H, Rodriguez W, Cardenas C, Bilbao J, Nojek C.

Interact Cardiovasc Thorac Surg. 2009 Aug;9(2):203-8. doi: 10.1510/icvts.2008.199083. Epub 2009 May 19.

PMID:
19454412
15.

Selecting a BRCA risk assessment model for use in a familial cancer clinic.

Panchal SM, Ennis M, Canon S, Bordeleau LJ.

BMC Med Genet. 2008 Dec 22;9:116. doi: 10.1186/1471-2350-9-116.

16.

Overview of risk prediction models in cardiovascular disease research.

Cui J.

Ann Epidemiol. 2009 Oct;19(10):711-7. doi: 10.1016/j.annepidem.2009.05.005. Epub 2009 Jul 22. Review.

PMID:
19628409
17.

Validation of prediction of diabetes by the Archimedes model and comparison with other predicting models.

Stern M, Williams K, Eddy D, Kahn R.

Diabetes Care. 2008 Aug;31(8):1670-1. doi: 10.2337/dc08-0521. Epub 2008 May 28.

18.

Development and validation of a risk scoring tool to predict respiratory syncytial virus hospitalization in premature infants born at 33 through 35 completed weeks of gestation.

Sampalis JS, Langley J, Carbonell-Estrany X, Paes B, O'Brien K, Allen U, Mitchell I, Aloy JF, Pedraz C, Michaliszyn AF.

Med Decis Making. 2008 Jul-Aug;28(4):471-80. doi: 10.1177/0272989X08315238. Epub 2008 Jun 12.

PMID:
18556643
19.

An accurate risk score for estimation 5-year risk of type 2 diabetes based on a health screening population in Taiwan.

Sun F, Tao Q, Zhan S.

Diabetes Res Clin Pract. 2009 Aug;85(2):228-34. doi: 10.1016/j.diabres.2009.05.005. Epub 2009 Jun 4.

PMID:
19500871
20.

Predicting prostate cancer risk through incorporation of prostate cancer gene 3.

Ankerst DP, Groskopf J, Day JR, Blase A, Rittenhouse H, Pollock BH, Tangen C, Parekh D, Leach RJ, Thompson I.

J Urol. 2008 Oct;180(4):1303-8; discussion 1308. doi: 10.1016/j.juro.2008.06.038. Epub 2008 Aug 15. Erratum in: J Urol. 2009 Mar;181(3):1507.

PMID:
18707724

Supplemental Content

Support Center